Conference abstractPublished 20 Jul 2022
The immunomodulation of SARS-COV-2 infection on the production of cytokines by peripheral blood mononuclear cells and neutrophils in COVID-19 ICU patients.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
COVID-19 pandemic is spreading globally with a worrying mortality rate. Unique medical features of severe COVID-19 include neutrophilia, cytokine storm, acute respiratory distress syndrome, and severe inflammatory syndrome. Here, we propose investigating the influence of SARS-CoV-2 infection on the cytokines profile of peripheral blood mononuclear cells (PBMC) and neutrophils in COVID-19 patients. This study examines PBMC and neutrophils as a potential source of immunopathologic complications for severely ill COVID-19 patients or as an immunomodulation target for SARS-CoV-2 infection. Neutrophils and PBMC were separated by density gradient sedimentation and stimulated with mitogen. Culture supernatants from 89 COVID-19 patients and 89 sex and age-matched healthy control (HC) were stimulated evaluated for levels of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF), interferon (IFN)- α, IFN-γ, interleukin (IL)-2, -4, -5, -6, -9, -10, -12, -17A, and tumor necrosis factor (TNF)-α using anticytokine antibody MACSPlex capture beads. The PBMC cytokine profiles showed significantly lower mean values of GM-CSF, IFN-γ, IL-6, IL-9, IL-10, IL-17A, and TNF-α (p < 0.0001) for COVID-19 patients compared to HC. In contrast, COVID-19 patients showed higher mean levels of PBMC cytokine values for IL-2 (p <0.001) and IL-5 (p <0.01). As for neutrophils, COVID-19 patients showed significantly lower mean values in the levels of GM-CSF, IFN-γ, IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-17A, IL-12, TNF-α (p < 0.0001), and IFN-α (p < 0.01). The Th1:Th2 cytokine ratios revealed a lower inflammatory cytokine for 12 out of 24 combinations in COVID-19 ICU patients, suggesting downregulation of the cellmediated immunity by SARS-CoV-2 infection for both the PBMC and neutrophils. Our finding may also indicate the source of raised serum cytokine levels (GM-CSF, IFN-α, IFN-γ, IL-4, IL-6, IL-9, IL-10, IL-17A, IL-12, and TNF-α) documented by previous studies in COVID-19 patients are not from PBMC or neutrophils but maybe from another cell type. We also detected a significant increase in the cytokine levels of IL-2 and IL-5 by PBMC, which may indicate that PBMC do play a part in the elevated IL-2 and IL-5 serum levels in COVID-19 patients. In conclusion, data collected for the cytokine profiles and Th1:Th2 cytokine ratios suggest that SARS-CoV-2 infection brings about an immunomodulatory effect on PBMC and neutrophils.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Medical Microbiology and Immunology Research
- SubjectImmunology & Microbiology
- SubjectMicrobiology
- BylineArticles whose byline prints “Sahar Essa”
